Laporan Laba Rugi (TTM)
Laporan Laba Rugi Mangalam Drugs & Organics Limited menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.
Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.
|
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3,507 | 3,774 | 3,800 | 3,813 | 4,058 | 4,185 | 4,509 | 4,505 | 4,426 | 4,109 | 3,702 | 3,477 | 3,245 | 3,595 | 3,674 | 3,568 | 3,552 | 3,467 | 3,176 | 2,983 |
| Change (%) | 7.63 | 0.67 | 0.34 | 6.44 | 3.13 | 7.73 | -0.08 | -1.74 | -7.17 | -9.91 | -6.07 | -6.68 | 10.77 | 2.20 | -2.86 | -0.45 | -2.39 | -8.41 | -6.07 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 2,415 | 2,563 | 2,558 | 2,540 | 2,773 | 2,880 | 3,101 | 3,053 | 3,020 | 2,705 | 2,536 | 2,426 | 2,226 | 2,405 | 2,472 | 2,190 | 2,117 | 1,934 | 1,674 | 1,665 |
| Change (%) | 6.13 | -0.19 | -0.69 | 9.17 | 3.84 | 7.68 | -1.55 | -1.08 | -10.42 | -6.27 | -4.34 | -8.25 | 8.06 | 2.78 | -11.39 | -3.36 | -8.66 | -13.44 | -0.50 | |
| % of Revenue | 68.86 | 67.90 | 67.32 | 66.63 | 68.34 | 68.81 | 68.78 | 67.77 | 68.22 | 65.84 | 68.50 | 69.76 | 68.59 | 66.91 | 67.29 | 61.39 | 59.59 | 55.76 | 52.70 | 55.83 |
| Gross Operating Profit | 1,092 | 1,212 | 1,242 | 1,272 | 1,285 | 1,305 | 1,408 | 1,452 | 1,407 | 1,404 | 1,166 | 1,052 | 1,019 | 1,189 | 1,201 | 1,378 | 1,435 | 1,534 | 1,502 | 1,318 |
| Change (%) | 10.94 | 2.48 | 2.47 | 0.98 | 1.60 | 7.83 | 3.14 | -3.13 | -0.21 | -16.92 | -9.83 | -3.07 | 16.69 | 1.02 | 14.69 | 4.17 | 6.86 | -2.07 | -12.29 | |
| % of Revenue | 31.14 | 32.10 | 32.68 | 33.37 | 31.66 | 31.19 | 31.22 | 32.23 | 31.78 | 34.16 | 31.50 | 30.24 | 31.41 | 33.09 | 32.71 | 38.61 | 40.41 | 44.24 | 47.30 | 44.17 |
| SG&A | 284 | 294 | 305 | 308 | 334 | 347 | 397 | 388 | 417 | 424 | 360 | 341 | 361 | 356 | 404 | 398 | 411 | 425 | 406 | 404 |
| Change (%) | 3.73 | 3.61 | 0.92 | 8.60 | 3.89 | 14.33 | -2.14 | 7.27 | 1.72 | -15.14 | -5.08 | 5.62 | -1.26 | 13.34 | -1.49 | 3.41 | 3.32 | -4.44 | -0.46 | |
| % of Revenue | 8.09 | 7.80 | 8.02 | 8.07 | 8.24 | 8.30 | 8.80 | 8.62 | 9.41 | 10.32 | 9.72 | 9.82 | 11.11 | 9.91 | 10.99 | 11.14 | 11.57 | 12.25 | 12.78 | 13.54 |
| R&D | ||||||||||||||||||||
| Change (%) | ||||||||||||||||||||
| % of Revenue | ||||||||||||||||||||
| OpEx | 3,155 | 3,349 | 3,355 | 3,408 | 3,704 | 3,822 | 4,121 | 4,154 | 4,078 | 3,897 | 3,556 | 3,479 | 3,280 | 3,669 | 3,646 | 3,429 | 3,349 | 3,251 | 2,984 | 2,924 |
| Change (%) | 6.14 | 0.19 | 1.57 | 8.71 | 3.19 | 7.80 | 0.80 | -1.81 | -4.44 | -8.77 | -2.16 | -5.71 | 11.87 | -0.65 | -5.94 | -2.32 | -2.94 | -8.22 | -2.01 | |
| % of Revenue | 89.96 | 88.72 | 88.29 | 89.37 | 91.27 | 91.33 | 91.39 | 92.20 | 92.14 | 94.85 | 96.05 | 100.04 | 101.09 | 102.08 | 99.24 | 96.09 | 94.29 | 93.76 | 93.95 | 98.01 |
| Operating Income | 352 | 426 | 445 | 405 | 354 | 363 | 388 | 351 | 348 | 212 | 146 | -1 | -35 | -75 | 28 | 140 | 203 | 216 | 192 | 59 |
| Change (%) | 20.93 | 4.47 | -8.89 | -12.63 | 2.48 | 6.92 | -9.49 | -0.90 | -39.22 | -30.82 | -100.95 | 2,421.12 | 112.62 | -137.36 | 398.63 | 45.47 | 6.66 | -11.23 | -69.12 | |
| % of Revenue | 10.04 | 11.28 | 11.71 | 10.63 | 8.73 | 8.67 | 8.61 | 7.80 | 7.86 | 5.15 | 3.95 | -0.04 | -1.09 | -2.08 | 0.76 | 3.91 | 5.71 | 6.24 | 6.05 | 1.99 |
| Interest Expense | -59 | -57 | -63 | -101 | -75 | -78 | -72 | -117 | -74 | -79 | -89 | -126 | -95 | -96 | -104 | -143 | -112 | -113 | -149 | -152 |
| Change (%) | -3.35 | 11.59 | 60.27 | -25.98 | 4.52 | -8.11 | 63.06 | -37.32 | 7.21 | 13.03 | 41.45 | -24.89 | 0.97 | 8.77 | 36.94 | -21.66 | 1.60 | 31.62 | 1.88 | |
| % of Revenue | -1.67 | -1.50 | -1.66 | -2.66 | -1.85 | -1.87 | -1.60 | -2.61 | -1.66 | -1.92 | -2.41 | -3.63 | -2.92 | -2.66 | -2.83 | -3.99 | -3.14 | -3.27 | -4.70 | -5.10 |
| Net Income | 261 | 309 | 280 | 241 | 175 | 151 | 197 | 182 | 159 | 123 | 13 | -113 | -171 | -170 | -91 | 31 | 94 | 102 | 67 | -98 |
| Change (%) | 18.33 | -9.39 | -13.87 | -27.22 | -13.76 | 30.01 | -7.18 | -12.62 | -22.56 | -89.71 | -987.34 | 51.38 | -0.42 | -46.60 | -134.70 | 198.65 | 8.39 | -34.06 | -245.26 | |
| % of Revenue | 7.44 | 8.18 | 7.36 | 6.32 | 4.32 | 3.61 | 4.36 | 4.05 | 3.60 | 3.00 | 0.34 | -3.24 | -5.26 | -4.73 | -2.47 | 0.88 | 2.65 | 2.94 | 2.12 | -3.27 |
Source: Capital IQ
